David Sidransky - Dec 31, 2021 Form 5 Insider Report for Orgenesis Inc. (ORGS)

Role
Director
Signature
/s/ David Sidransky
Stock symbol
ORGS
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/14/2022, 03:50 PM
Previous filing
Nov 9, 2021
Next filing
Jun 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORGS Stock Option (Right to Buy) Award $0 +2.05K +11.11% $0.00 20.5K Dec 16, 2021 Common Stock 20.5K $2.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 16, 2021, the Board granted the Reporting Person options to purchase 20,450 shares at the exercise price of $2.89 per share. The options vest in full one year from the date of grant.